<< [Back to News Releases]


Snowden-Pencer® instruments facilitate sterilization, enhance ergonomics and performance

Nov 1, 2012

SAN DIEGO, Nov. 1, 2012 — CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today announced it recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new Snowden-Pencer® take-apart laparoscopic scissors.

The scissors are the latest in CareFusion’s line of take-apart laparoscopic surgical instruments and provide sterile, sharp blades and a new insulated shaft for each procedure. Designed for easy assembly and disassembly, the scissors feature an ergonomic, reusable ring-handle that also fits Snowden-Pencer take-apart clamps, dissectors and graspers. The handle is designed to reduce interoperative hand fatigue and accommodate a variety of hand positions for comfort and precision during surgery. Currently in limited market release, the new Snowden-Pencer laparoscopic scissors are expected to be commercially available in early 2013.

Snowden-Pencer take-apart scissors provide a fresh blade and insulated shaft for each use —reducing the need to clean and inspect the shaft and insulation — delivering potential cost savings compared to fully disposable scissors. Newly engineered and tested for use on various surgical materials and for consistent mixed hot and cold cutting without snagging, the scissors also come with the reassurance of a lifetime warranty against manufacturing defects.

The 510(k) clearance covers Snowden-Pencer scissors in Metzenbaum, Mini-Metzenbaum and hook-blade configurations – in both 36 and 45 millimeter sizes.

“Our new Snowden-Pencer scissors are designed for sterility and product safety for patients and to provide exceptional performance and ease-of-use for surgeons and medical personnel,” said Andreas Lex, vice president and general manager of V. Mueller® and Snowden-Pencer surgical instruments for CareFusion. “These new scissors are a complementary addition to our growing line of take-apart instruments and to our already extensive portfolio of products dedicated to performance.”

For more than 50 years, Snowden-Pencer instruments from CareFusion have offered exceptional levels of performance and longevity. For more information, call 800.323.9088 or visit www.CareFusion.com/SnowdenPencer.


About CareFusion
CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops market-leading technologies including Alaris® infusion pumps, Pyxis® automated dispensing and patient identification systems, AVEA®, AirLife™ and LTV® series ventilation and respiratory products, ChloraPrep® products, MedMined® services for data mining surveillance, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine. CareFusion employs more than 15,000 people across its global operations. More information may be found at www.carefusion.com.


Editor’s Note: High-resolution product images available upon request.

For further information:
Media: Troy Kirkpatrick (858) 617-2361 [email protected]
Investors: Jim Mazzola (858) 617-1203 [email protected]

RSS Print
rss print